Medindia3d
VARIANT Receives Positive Feedback from the European Medicines Agency (EMA) for its Innovative Gene Replacement Therapy, VAR002
Variant, a company dedicated to developing innovative treatments for orphan inherited eye diseases, and the Rare Ocular Diseases Center at the University ofCampania Luigi Vanvitelli ...
BioWorld3d
Variant advances ocular gene therapy VAR-002 based on feedback from EMA
Variant SAS and the Rare Ocular Diseases Center at the University of Campania Luigi Vanvitelli (UCLV) have received positive feedback from the EMA for VAR-002, a recombinant AAV vector gene therapy ...